Showing 4401-4420 of 8668 for: Cochrane Systematic Reviews Back
- Iron therapy in anaemic adults without chronic kidney disease
Cochrane Systematic Reviews, 30-Dec-2014
Anaemia affects about a quarter of the world's population. An estimated 50% of anaemic people have anaemia due to iron deficiency.
- Iron‐chelating agents for treating malaria
Cochrane Systematic Reviews, 22-Apr-2003
It is still unclear whether iron-chelating agents, such as intravenous desferrioxamine (DFO) and oral deferiprone, given alone or added to standard antimalarial treatment would reduce malaria deaths.
- Irrigants for non-surgical root canal treatment in mature permanent teeth
Cochrane Systematic Reviews, 8-Aug-2012
Root canal treatment is carried out on teeth in which irreversible pulpitis has led to necrosis of the dental pulp. As a treatment option it is an alternative to dental extraction. Mechanical preparation and irrigation with antiseptic or antibacterial sol
- Ischaemic pre‐conditioning for elective liver resections performed under vascular occlusion
Cochrane Systematic Reviews, 21-Jan-2009
Vascular occlusion is used to reduce blood loss during liver resection surgery. The enzyme markers of liver injury are elevated if vascular occlusion is employed during liver resection. It is not clear whether ischaemic preconditioning prior to vascular o
- Ischaemic preconditioning for liver transplantation
Cochrane Systematic Reviews, 11-Nov-2008
Ischaemic preconditioning is a mechanism for reducing organ ischaemia reperfusion injury by a brief period of organ ischaemia.
- Ischaemic preconditioning for the reduction of renal ischaemia reperfusion injury
Cochrane Systematic Reviews, 4-Mar-2017
Ischaemia reperfusion injury can lead to kidney dysfunction or failure. Ischaemic preconditioning is a short period of deprivation of blood supply to particular organs or tissue, followed by a period of reperfusion. It has the potential to protect kidneys
- Isocaloric balanced protein supplementation in pregnancy
Cochrane Systematic Reviews, 23-Oct-2008
Background pending.
- Isoflavones for hypercholesterolaemia in adults
Cochrane Systematic Reviews, 16-May-2013
Hypercholesterolaemia is a significant risk factor for cardiovascular diseases. Isoflavones may be effective in improving hypercholesterolaemia.
- Isolation as a strategy for controlling the transmission of hepatitis C virus (HCV) infection in haemodialysis units
Cochrane Systematic Reviews, 11-Aug-2016
The hepatitis C virus (HCV) infection affects about 2% of the world's population and can cause chronic liver infection and persistent long-term sequelae such as cirrhosis and liver cancer.
- Isoniazid for preventing tuberculosis in HIV-infected children
Cochrane Systematic Reviews, 23-Aug-2017
Tuberculosis (TB) is an important cause of illness and death in HIV-positive children living in areas of high TB prevalence. We know that isoniazid prophylaxis prevents TB in HIV-negative children following TB exposure, but there is uncertainty related to
- Isoniazid for preventing tuberculosis in non‐HIV infected persons
Cochrane Systematic Reviews, 25-Jan-1999
Although isoniazid (INH) is commonly used for treating tuberculosis (TB), it is also effective as preventive therapy.
- Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children
Cochrane Systematic Reviews, 15-Dec-2014
Maintenance intravenous fluids are frequently used in hospitalised children who cannot maintain adequate hydration through enteral intake. Traditionally used hypotonic fluids have been associated with hyponatraemia and subsequent morbidity and mortality.
- Ivabradine as adjuvant treatment for chronic heart failure
Cochrane Systematic Reviews, 4-Nov-2020
Chronic heart failure is one of the most common medical conditions, affecting more than 23 million people worldwide. Despite established guideline-based, multidrug pharmacotherapy, chronic heart failure is still the cause of frequent hospitalisation, and
- Ivermectin and permethrin for treating scabies
Cochrane Systematic Reviews, 2-Apr-2018
Scabies is an intensely itchy parasitic infection of the skin. It occurs worldwide, but is particularly problematic in areas of poor sanitation, overcrowding, and social disruption. In recent years, permethrin and ivermectin have become the most relevant
- Ivermectin for onchocercal eye disease (river blindness)
Cochrane Systematic Reviews, 15-Aug-2012
It is believed that ivermectin (a microfilaricide) could prevent blindness due to onchocerciasis. However, when given to everyone in communities where onchocerciasis is common, the effects of ivermectin on lesions affecting the eye are uncertain and data
- Ivermectin for preventing and treating COVID‐19
Cochrane Systematic Reviews, 28-Jul-2021
Ivermectin, an antiparasitic agent used to treat parasitic infestations, inhibits the replication of viruses in vitro. The molecular hypothesis of ivermectin's antiviral mode of action suggests an inhibitory effect on severe acute respiratory syndrome cor
- Ivermectin treatment in humans for reducing malaria transmission
Cochrane Systematic Reviews, 29-Jun-2021
Malaria is transmitted through the bite of Plasmodium-infected adult female Anopheles mosquitoes. Ivermectin, an anti-parasitic drug, acts by killing mosquitoes that are exposed to the drug while feeding on the blood of people (known as blood feeds) who h
- Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection
Cochrane Systematic Reviews, 5-Jan-2016
Strongyloidiasis is a gut infection with Strongyloides stercoralis which is common world wide. Chronic infection usually causes a skin rash, vomiting, diarrhoea or constipation, and respiratory problems, and it can be fatal in people with immune deficienc
- Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis
Cochrane Systematic Reviews, 10-Apr-2015
Myelofibrosis is a bone marrow disorder characterized by excessive production of reticulin and collagen fiber deposition caused by hematological and non-hematological disorders. The prognosis of myelofibrosis is poor and treatment is mainly palliative. Ja
- Joint lavage for osteoarthritis of the knee
Cochrane Systematic Reviews, 13-Apr-2010
Osteoarthritis is the most common form of joint disorder and a leading cause of pain and physical disability. Observational studies suggested a benefit for joint lavage, but recent, sham-controlled trials yielded conflicting results, suggesting joint lava
